Works by Hajek, Roman

Results: 252
    1
    2
    3

    Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial).

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 102, doi. 10.1002/jha2.130
    By:
    • Ludwig, Heinz;
    • Hausmann, Bela;
    • Schreder, Martin;
    • Pönisch, Wolfram;
    • Zojer, Niklas;
    • Knop, Stefan;
    • Gunsilius, Eberhard;
    • Egle, Alexander;
    • Petzer, Andreas;
    • Einsele, Hermann;
    • Hajek, Roman;
    • Weisel, Katja;
    • Krenosz, Karl Jochen;
    • Lang, Alois;
    • Lechner, Daniel;
    • Greil, Richard;
    • Berry, David
    Publication type:
    Article
    4

    Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib.

    Published in:
    EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.4
    By:
    • Richardson, Paul G.;
    • Nagler, Arnon;
    • Ben-Yehuda, Dina;
    • Badros, Ashraf;
    • Hari, Parameswaran N.;
    • Hajek, Roman;
    • Spicka, Ivan;
    • Kaya, Hakan;
    • LeBlanc, Richard;
    • Sung-Soo Yoon;
    • Kihyun Kim;
    • Martinez-Lopez, Joaquin;
    • Moshe Mittelman;
    • Shpilberg, Ofer;
    • Blake, Paul;
    • Teru Hideshima;
    • Colson, Kathleen;
    • Laubach, Jacob P.;
    • Ghobrial, Irene M.;
    • Leiba, Merav
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre‐Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 704, doi. 10.1002/ajh.27590
    By:
    • Venglar, Ondrej;
    • Radova, Eva;
    • Zihala, David;
    • Tvrda, Ivana;
    • Kubala, Viktor;
    • Kutejova, Kamila;
    • Muronova, Ludmila;
    • Kapustova, Veronika;
    • Broskevicova, Lucie;
    • Vrana, Jan;
    • Popkova, Tereza;
    • Mihalyova, Jana;
    • Plonkova, Hana;
    • Sevcikova, Tereza;
    • Kascak, Michal;
    • Navratil, Milan;
    • Koristek, Zdenek;
    • Hajek, Roman;
    • Jelinek, Tomas
    Publication type:
    Article
    13

    Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1746, doi. 10.1002/ajh.27382
    By:
    • Delimpasi, Sosana;
    • Dimopoulos, Meletios A.;
    • Straub, Jan;
    • Symeonidis, Argiris;
    • Pour, Luděk;
    • Hájek, Roman;
    • Touzeau, Cyrille;
    • Bhanderi, Viralkumar K.;
    • Berdeja, Jesus G.;
    • Pavlíček, Petr;
    • Matous, Jeffrey V.;
    • Robak, Pawel J.;
    • Suryanarayan, Kaveri;
    • Miller, Alison;
    • Villarreal, Miguel;
    • Cherepanov, Dasha;
    • Srimani, Jaydeep K.;
    • Yao, Huilan;
    • Labotka, Richard;
    • Orlowski, Robert Z.
    Publication type:
    Article
    14

    Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. E15, doi. 10.1002/ajh.26602
    By:
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Augustson, Bradley;
    • Castro, Nelson;
    • Pika, Tomas;
    • Delimpasi, Sosana;
    • De la Rubia, Javier;
    • Maiolino, Angelo;
    • Reiman, Tony;
    • Martinez‐Lopez, Joaquin;
    • Martin, Thomas;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Risse, Marie‐Laure;
    • Asset, Gaelle;
    • Marion, Sylvia;
    • Hajek, Roman
    Publication type:
    Article
    15
    16

    Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434
    By:
    • Delimpasi, Sosana;
    • Mateos, Maria Victoria;
    • Auner, Holger W.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.;
    • Quach, Hang;
    • Pylypenko, Halyna;
    • Hájek, Roman;
    • Leleu, Xavier;
    • Dolai, Tuphan Kanti;
    • Sinha, Dinesh Kumar;
    • Venner, Christopher P.;
    • Benjamin, Reuben;
    • Garg, Mamta Krishnan;
    • Doronin, Vadim;
    • Levy, Yair;
    • Moreau, Philippe;
    • Chai, Yi;
    • Arazy, Melina;
    • Shah, Jatin
    Publication type:
    Article
    17

    Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E383, doi. 10.1002/ajh.26282
    By:
    • Sanchez, Larysa;
    • Leleu, Xavier;
    • Beaumont, Jennifer L.;
    • Yu, Hailin;
    • Hudgens, Stacie;
    • Simonova, Maryana;
    • Auner, Holger W.;
    • Quach, Hang;
    • Delimpasi, Sosana;
    • Špička, Ivan;
    • Pour, Ludĕk;
    • Kriachok, Iryna;
    • Dimopoulos, Meletios A.;
    • Usenko, Ganna;
    • Hájek, Roman;
    • Benjamin, Reuben;
    • Sinha, Dinesh Kumar;
    • Venner, Christopher;
    • Illmer, Thomas;
    • Garg, Mamta Krishnan
    Publication type:
    Article
    18

    Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 9, p. 1120, doi. 10.1002/ajh.26261
    By:
    • Richard, Shambavi;
    • Chari, Ajai;
    • Delimpasi, Sosana;
    • Simonova, Maryana;
    • Spicka, Ivan;
    • Pour, Ludek;
    • Kriachok, Iryna;
    • Dimopoulos, Meletios A.;
    • Pylypenko, Halyna;
    • Auner, Holger W.;
    • Leleu, Xavier;
    • Usenko, Ganna;
    • Hajek, Roman;
    • Benjamin, Reuben;
    • Dolai, Tuphan Kanti;
    • Sinha, Dinesh Kumar;
    • Venner, Christopher P.;
    • Garg, Mamta;
    • Stevens, Don Ambrose;
    • Quach, Hang
    Publication type:
    Article
    19

    Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 6, p. 708, doi. 10.1002/ajh.26172
    By:
    • Auner, Holger W.;
    • Gavriatopoulou, Maria;
    • Delimpasi, Sosana;
    • Simonova, Maryana;
    • Spicka, Ivan;
    • Pour, Ludek;
    • Dimopoulos, Meletios A.;
    • Kriachok, Iryna;
    • Pylypenko, Halyna;
    • Leleu, Xavier;
    • Doronin, Vadim;
    • Usenko, Ganna;
    • Hajek, Roman;
    • Benjamin, Reuben;
    • Dolai, Tuphan Kanti;
    • Sinha, Dinesh Kumar;
    • Venner, Christopher P.;
    • Garg, Mamta;
    • Stevens, Don Ambrose;
    • Quach, Hang
    Publication type:
    Article
    20

    Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14).

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 1, p. E35, doi. 10.1002/ajh.25331
    By:
    • Jelinek, Tomas;
    • Mihalyova, Jana;
    • Kascak, Michal;
    • Duras, Juraj;
    • Popkova, Tereza;
    • Benkova, Katerina;
    • Richterova, Petra;
    • Plonkova, Hana;
    • Zuchnicka, Jana;
    • Broskevicova, Lucie;
    • Huvarova, Lucie;
    • Cerna, Lucie;
    • Growkova, Katerina;
    • Simicek, Michal;
    • Havel, Martin;
    • Gumulec, Jaromir;
    • Navratil, Milan;
    • Koristek, Zdenek;
    • Paiva, Bruno;
    • Hajek, Roman
    Publication type:
    Article
    21

    IgM myeloma: A multicenter retrospective study of 134 patients.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 746, doi. 10.1002/ajh.24753
    By:
    • Castillo, Jorge J.;
    • Jurczyszyn, Artur;
    • Brozova, Lucie;
    • Crusoe, Edvan;
    • Czepiel, Jacek;
    • Davila, Julio;
    • Dispenzieri, Angela;
    • Eveillard, Marion;
    • Fiala, Mark A.;
    • Ghobrial, Irene M.;
    • Gozzetti, Alessandro;
    • Gustine, Joshua N.;
    • Hajek, Roman;
    • Hungria, Vania;
    • Jarkovsky, Jiri;
    • Jayabalan, David;
    • Laubach, Jacob P.;
    • Lewicka, Barbara;
    • Maisnar, Vladimir;
    • Manasanch, Elisabet E.
    Publication type:
    Article
    22
    23

    Long Non-Coding RNAs in Multiple Myeloma.

    Published in:
    Non-Coding RNA, 2019, v. 5, n. 1, p. 1, doi. 10.3390/ncrna5010013
    By:
    • Butova, Romana;
    • Vychytilova-Faltejskova, Petra;
    • Souckova, Adela;
    • Sevcikova, Sabina;
    • Hajek, Roman
    Publication type:
    Article
    24

    European Perspective on Multiple Myeloma Treatment Strategies in 2014.

    Published in:
    2014
    By:
    • Ludwig, Heinz;
    • Sonneveld, Pieter;
    • Davies, Faith;
    • Bladé, Joan;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • Morgan, Gareth;
    • de la Rubia, Javier;
    • Delforge, Michel;
    • Dimopoulos, Meletios;
    • Einsele, Hermann;
    • Facon, Thierry;
    • Goldschmidt, Hartmut;
    • Moreau, Philippe;
    • Nahi, Hareth;
    • Plesner, Torben;
    • San-Miguel, Jesús;
    • Hajek, Roman;
    • Sondergeld, Pia;
    • Palumbo, Antonio
    Publication type:
    Journal Article
    25

    European Perspective on Multiple Myeloma Treatment Strategies in 2014.

    Published in:
    Oncologist, 2014, v. 19, n. 8, p. 829, doi. 10.1634/theoncologist.2014-0042
    By:
    • Ludwig, Heinz;
    • Sonneveld, Pieter;
    • Davies, Faith;
    • Bladé, Joan;
    • Boccadoro, Mario;
    • Cavo, Michele;
    • Morgan, Gareth;
    • Rubia, Javier;
    • Delforge, Michel;
    • Dimopoulos, Meletios;
    • Einsele, Hermann;
    • Facon, Thierry;
    • Goldschmidt, Hartmut;
    • Moreau, Philippe;
    • Nahi, Hareth;
    • Plesner, Torben;
    • San‐Miguel, Jesús;
    • Hajek, Roman;
    • Sondergeld, Pia;
    • Palumbo, Antonio
    Publication type:
    Article
    26

    Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.

    Published in:
    Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102535
    By:
    • Stork, Martin;
    • Sevcikova, Sabina;
    • Jelinek, Tomas;
    • Minarik, Jiri;
    • Radocha, Jakub;
    • Pika, Tomas;
    • Pospisilova, Lenka;
    • Spicka, Ivan;
    • Straub, Jan;
    • Pavlicek, Petr;
    • Jungova, Alexandra;
    • Knechtova, Zdenka;
    • Sandecka, Viera;
    • Maisnar, Vladimir;
    • Hajek, Roman;
    • Pour, Ludek
    Publication type:
    Article
    27

    Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.

    Published in:
    Cancer Medicine, 2018, v. 7, n. 8, p. 4132, doi. 10.1002/cam4.1620
    By:
    • Radocha, Jakub;
    • Maisnar, Vladimír;
    • Heindorfer, Adriana;
    • Kessler, Petr;
    • Mikula, Peter;
    • Sýkora, Michal;
    • Wróbel, Marek;
    • Pour, Luděk;
    • Krejčí, Marta;
    • Špička, Ivan;
    • Straub, Jan;
    • Minařík, Jiři;
    • Pika, Tomáš;
    • Szeligová, Lenka;
    • Hájek, Roman;
    • Pavlíček, Petr;
    • Jungová, Alexandra;
    • Jindra, Pavel;
    • Brožová, Lucie;
    • Jarkovský, Jiří
    Publication type:
    Article
    28
    29

    Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01121-8
    By:
    • Thomsen, Hauke;
    • Chattopadhyay, Subhayan;
    • Weinhold, Niels;
    • Vodicka, Pavel;
    • Vodickova, Ludmila;
    • Hoffmann, Per;
    • Nöthen, Markus M.;
    • Jöckel, Karl-Heinz;
    • Schmidt, Börge;
    • Hajek, Roman;
    • Hallmans, Göran;
    • Pettersson-Kymmer, Ulrika;
    • Späth, Florentin;
    • Goldschmidt, Hartmut;
    • Hemminki, Kari;
    • Försti, Asta
    Publication type:
    Article
    30

    Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    2023
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Correction Notice
    31

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    32

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    33

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    34

    Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00791-0
    By:
    • Ogiya, Daisuke;
    • Chyra, Zuzana;
    • Verselis, Sigitas J.;
    • O'Keefe, Morgan;
    • Cobb, Jacquelyn;
    • Abiatari, Ivane;
    • Talluri, Srikanth;
    • Sithara, Anjana Anilkumar;
    • Hideshima, Teru;
    • Chu, Michael P.;
    • Hájek, Roman;
    • Dorfman, David M.;
    • Pilarski, Linda M.;
    • Anderson, Kenneth C.;
    • Adamia, Sophia
    Publication type:
    Article
    35

    The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00789-8
    By:
    • Palladini, Giovanni;
    • Schönland, Stefan;
    • Merlini, Giampaolo;
    • Milani, Paolo;
    • Jaccard, Arnaud;
    • Bridoux, Frank;
    • Dimopoulos, Meletios A.;
    • Ravichandran, Sriram;
    • Hegenbart, Ute;
    • Roeloffzen, Wilfried;
    • Cibeira, M. Teresa;
    • Agis, Hermine;
    • Minnema, Monique C.;
    • Bergantim, Rui;
    • Hájek, Roman;
    • João, Cristina;
    • Leonidakis, Alexandros;
    • Cheliotis, Giorgos;
    • Sonneveld, Pieter;
    • Kastritis, Efstathios
    Publication type:
    Article
    36

    Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6.

    Published in:
    2022
    By:
    • Clay-Gilmour, Alyssa;
    • Chattopadhyay, Subhayan;
    • Hildebrandt, Michelle A. T.;
    • Thomsen, Hauke;
    • Weinhold, Niels;
    • Vodicka, Pavel;
    • Vodickova, Ludmila;
    • Hoffmann, Per;
    • Nöthen, Markus M.;
    • Jöckel, Karl-Heinz;
    • Schmidt, Börge;
    • Langer, Christian;
    • Hajek, Roman;
    • Hallmans, Göran;
    • Pettersson-Kymmer, Ulrika;
    • Ohlsson, Claes;
    • Späth, Florentin;
    • Houlston, Richard;
    • Goldschmidt, Hartmut;
    • Manasanch, Elisabet E.
    Publication type:
    Letter
    37

    Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00498-0
    By:
    • Oliva, Stefania;
    • Bruinink, Davine Hofste op;
    • Rihova, Lucie;
    • D'Agostino, Mattia;
    • Pantani, Lucia;
    • Capra, Andrea;
    • van der Holt, Bronno;
    • Troia, Rossella;
    • Petrucci, Maria Teresa;
    • Villanova, Tania;
    • Vsianska, Pavla;
    • Jugooa, Romana;
    • Brandt-Hagens, Claudia;
    • Gilestro, Milena;
    • Offidani, Massimo;
    • Ribolla, Rossella;
    • Galli, Monica;
    • Hajek, Roman;
    • Gay, Francesca;
    • Cavo, Michele
    Publication type:
    Article
    38
    39

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    40
    41

    Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69408-1
    By:
    • Vlachová, Monika;
    • Pečinka, Lukáš;
    • Gregorová, Jana;
    • Moráň, Lukáš;
    • Růžičková, Tereza;
    • Kovačovicová, Petra;
    • Almáši, Martina;
    • Pour, Luděk;
    • Štork, Martin;
    • Hájek, Roman;
    • Jelínek, Tomáš;
    • Popková, Tereza;
    • Večeřa, Marek;
    • Havel, Josef;
    • Vaňhara, Petr;
    • Ševčíková, Sabina
    Publication type:
    Article
    42
    43
    44

    Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.

    Published in:
    Cells (2073-4409), 2021, v. 10, n. 5, p. 967, doi. 10.3390/cells10050967
    By:
    • Motais, Benjamin;
    • Charvátová, Sandra;
    • Walek, Zuzana;
    • Hrdinka, Matouš;
    • Smolarczyk, Ryszard;
    • Cichoń, Tomasz;
    • Czapla, Justyna;
    • Giebel, Sebastian;
    • Šimíček, Michal;
    • Jelínek, Tomáš;
    • Ševčíková, Tereza;
    • Sobotka, Jiří;
    • Kořístek, Zdeněk;
    • Hájek, Roman;
    • Bagó, Juli R.;
    • Kalyuzhny, Alexander E.
    Publication type:
    Article
    45
    46

    Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 920, doi. 10.3109/10428194.2011.634042
    By:
    • Nemec, Pavel;
    • Zemanova, Zuzana;
    • Kuglik, Petr;
    • Michalova, Kyra;
    • Tajtlova, Jana;
    • Kaisarova, Petra;
    • Oltova, Alexandra;
    • Filkova, Hana;
    • Holzerova, Milena;
    • Balcarkova, Jana;
    • Jarosova, Marie;
    • Rabasova, Jana;
    • Hruba, Martina;
    • Spicka, Ivan;
    • Gregora, Evzen;
    • Adam, Zdenek;
    • Scudla, Vlastimil;
    • Maisnar, Vladimir;
    • Schutzova, Miroslava;
    • Hajek, Roman
    Publication type:
    Article
    47

    MyelomA Genetics International Consortium.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 796, doi. 10.3109/10428194.2011.639881
    By:
    • Morgan, Gareth;
    • Johnsen, Hans Erik;
    • Goldschmidt, Hartmut;
    • Palumbo, Antonio;
    • Cavo, Michele;
    • Sonneveld, Pieter;
    • Miguel, Jesus San;
    • Chim, Char Sang;
    • Browne, Paul;
    • Einsele, Hermann;
    • Waage, Anders;
    • Turesson, Ingemar;
    • Spencer, Andrew;
    • Hajek, Roman;
    • Ludwig, Heinz;
    • Hemminki, Kari;
    • Houlston, Richard
    Publication type:
    Article
    48

    Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 4, p. 743, doi. 10.3109/10428194.2011.627482
    By:
    • Szturz, Petr;
    • Adam, Zdeněk;
    • Chovancová, Jana;
    • Stehlíková, Olga;
    • Klabusay, Martin;
    • Feit, Josef;
    • Křen, Leoš;
    • Fojtík, Zdeněk;
    • Krejčí, Marta;
    • Pour, Luděk;
    • Hájek, Roman;
    • Mayer, Jiří
    Publication type:
    Article
    49
    50